70 filings
8-K
NEOS
Neos Therapeutics, Inc.
22 Mar 21
Aytu BioScience Announces Close of Merger with Neos Therapeutics
6:11am
8-K
NEOS
Neos Therapeutics, Inc.
8 Feb 21
Entry into a Material Definitive Agreement
4:14pm
8-K
NEOS
Neos Therapeutics, Inc.
11 Jan 21
Corporate Presentation January 2021
8:45am
8-K
NEOS
Neos Therapeutics, Inc.
30 Dec 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
NEOS
Neos Therapeutics, Inc.
11 Dec 20
Entry into a Material Definitive Agreement
6:01am
8-K
na8usqow8kuag26
10 Dec 20
Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue1 Specialty Pharmaceutical Company
8:21am
8-K
ij9mr
9 Nov 20
Neos Therapeutics Reports Third Quarter 2020 Financial Results
7:29am
8-K
h4eu4ipvq4sj21uk1
10 Aug 20
Neos Therapeutics Reports Second Quarter 2020 Financial Results
7:11am
8-K
ixtg 91av1sn
19 Jun 20
Departure of Directors or Certain Officers
5:05pm
8-K
w5nfkb8bi2s gan5bdso
11 Jun 20
Entry into a Material Definitive Agreement
4:21pm
8-K
mg5a32qvq
3 Jun 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
spxocs35b9drglekc
11 May 20
Neos Therapeutics Reports First Quarter 2020 Financial Results
4:17pm
8-K
0fhqchnj
7 May 20
Entry into a Material Definitive Agreement
9:23am
8-K
hpdts9ind clh
23 Apr 20
Entry into a Material Definitive Agreement
4:23pm
8-K
gcvje zybeb
9 Apr 20
Neos Therapeutics Announces Issuance of New U.S. Methods of Use
8:18am
8-K
tjhr8c9v
30 Mar 20
Regulation FD Disclosure
8:12am
8-K
hypeq2
13 Mar 20
Neos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results
8:04am
8-K
g9pwz88s9y
8 Nov 19
Neos Therapeutics Reports Third Quarter 2019 Financial Results
7:22am
8-K
fvh vzmjfz
3 Oct 19
Entry into a Material Definitive Agreement
6:05am
8-K
6qbz5hg6xc5
8 Aug 19
Neos Therapeutics Reports Second Quarter 2019 Financial Results
7:15am